Preterm labor drugs under scrutiny: do they harm the fetal heart?
NCT ID NCT06904534
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 pregnant women between 24 and 34 weeks of pregnancy who are given either nifedipine or magnesium sulfate to stop preterm labor. Researchers use ultrasound to check the baby's heart function before and 48 hours after treatment. The goal is to see if these drugs have any unexpected effects on the fetal heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNEXPECTED FETAL CARDIAC EFFECTS OF NIFEDIPINE AND MGSO4 are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Şanlıurfa Training and Research Hospital
Sanliurfa, 63100, Turkey (Türkiye)